JSC Grindeks

JSC Grindeks

JSC Grindeks is the leading pharmaceutical company in the Baltic States.

Its main fields of action are: research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients.

JSC Grindeks Group consists of four subsidiary companies in countries: Latvia, Estonia and Russia, as well as representative offices in 13 countries.

Kalendorius:

JSC Grindeks plans to publish its:

  • non-audited interim financial statement for the 12-month period of 2018 on 28 February 2019;
  • non-audited interim financial statement for the 3-month period of 2019 on 30 May 2019;
  • non-audited interim financial statement for the 6-month period of 2019 on 29 August 2019;
  • non-audited interim financial statement for the 9-month period of 2019 on 28 November 2019.

The audited separate and consolidated financial statement of Grindeks JSC of 2018 is scheduled for 30 April 2019.


 

Facebook Komentarai
%d bloggers like this: